Ciatto Stefano
CSPO Istituto Scientifico per la Prevenzione Oncologica, Viale A, Volta 171, 50131 Firenze, Italy.
Womens Health (Lond). 2008 Jul;4(4):333-5. doi: 10.2217/17455057.4.4.333.
Evaluation of: Badgwell BB, Giordano SH, Duan ZZ et al.: Mammography before diagnosis among women age 80 years and older with breast cancer. J. Clin. Oncol. 26, 5-8 (2008). While strong scientific evidence of efficacy supports the recommendation of mammography screening up to the age of 74 years, the current recommendation of continuing screening up to or beyond the age of 80 years, issued by several guidelines, is not based on controlled evidence of screening efficacy, but simply on the assumption that mammography increases its accuracy with age and that mammography screening must be beneficial, providing that life expectancy is long enough to allow for the benefit to take place. In the present study, a large series of breast cancer patients aged 80 years or above was considered, demonstrating that mammography use is associated with less advanced stage at diagnosis and with better survival. The authors conclude that the opportunity for continuing screening beyond the age of 80 years, owing to its potential benefit, should be discussed with patients, particularly those without significant comorbidity, foretelling a longer life expectancy. Although their findings may also suggest a benefit in terms of mortality reduction, the clear presence of a healthy screening effect, lead time and overdiagnosis considerations call for major caution, since screening might be more detrimental than beneficial.
Badgwell BB、Giordano SH、Duan ZZ等人所著的《80岁及以上乳腺癌女性患者诊断前的乳腺钼靶检查》,发表于《临床肿瘤学杂志》26卷,第5 - 8页(2008年)。虽然有强有力的科学证据支持对74岁及以下人群进行乳腺钼靶筛查的建议,但目前一些指南所发布的将筛查年龄持续至80岁及以上的建议,并非基于筛查效果的对照证据,而仅仅基于这样的假设:乳腺钼靶检查的准确性会随年龄增长而提高,并且只要预期寿命足够长以实现获益,乳腺钼靶筛查就必定有益。在本研究中,纳入了大量80岁及以上的乳腺癌患者,结果表明乳腺钼靶检查的使用与诊断时较早期别以及更好的生存率相关。作者得出结论,鉴于其潜在益处,对于80岁以上的患者,尤其是那些没有严重合并症、预期寿命较长的患者,应与其讨论继续进行筛查的机会。尽管他们的研究结果可能也表明在降低死亡率方面存在益处,但由于存在明确的健康筛查效应、领先时间和过度诊断等考虑因素,仍需极度谨慎,因为筛查可能弊大于利。